Algert Global LLC Cytokinetics Inc Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Algert Global LLC holds 48,670 shares of CYTK stock, worth $2.44 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

48,670

Previous 71,408 31.84%

Holding current value

$2.44 Million

Previous $3.87 Million 33.57%

% of portfolio

0.07%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$51.22 - $60.16 $1.16 Million - $1.37 Million	-22,738 Reduced 31.84%	48,670 $2.57 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $1.33 Million - $2.08 Million	27,738 Added 63.52%	71,408 $3.87 Million
Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $9,562 - $16,209	-150 Reduced 0.34%	43,670 $3.06 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $762,585 - $2.37 Million	28,370 Added 183.62%	43,820 $3.66 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $455,157 - $565,624	15,450 New	15,450 $455,000
Q3 2022 Nov 15, 2022	BUY	$38.54 - $54.52 $228,041 - $322,594	5,917 Added 17.81%	39,143 $1.9 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $12,146 - $17,513	358 Added 1.09%	33,226 $1.31 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $831,173 - $1.29 Million	27,948 Added 568.05%	32,868 $1.21 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $169,002 - $228,189	4,920 New	4,920 $224,000
Q1 2021 May 14, 2021	SELL	$18.57 - $25.68 $681,221 - $942,045	-36,684 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $559,797 - $1.05 Million	36,684 New	36,684 $762,000
Q4 2019 Feb 18, 2020	SELL	$7.95 - $11.84 $114,384 - $170,353	-14,388 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $155,678 - $205,029	14,388 New	14,388 $164,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.73B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Cytokinetics Inc Transaction History